Co-Director Carcinoid and Neuroendocrine Cancer Program Cedars-Sinai Medical Center
Oncology
Dr. Edward M. Wolin, MD
|
|
Give Review
Doctor Edward M. Wolin, MD is an expert in the field of Oncology. He researched medicine at Yale University School of Medicine. Yale University School of Medicine is a one of the best medicals schools. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He has 5 awards "Patient’s Choice Physician Award", "Excellence Award", "Member", "Class of 1911 Prize – Most Outstanding Undergraduate Thesis" and "Super Doctor". Edward M. Wolin is also a published doctor. He has 23 paper published. The most recent paper is: Uptake of the yolk protein, lipovitellin, by developing crustacean oocytes. Edward M. Wolin accepts Medicare payments and is listed with Medicare.gov.
Publications
- Anti-tumour effects of lanreotide for pancreatic and intestinal Neuroendocrine tumours: the CLARINET open-label extension study.
- Impact of 68Ga-DOTATATE PET/CT on the management of Neuroendocrine tumors: the referring physician's perspective.
- Impact of Prior Chemotherapy Use on the Efficacy of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors: A Subgroup Analysis of the Phase III RADIANT...
- Pharmacokinetic study of aldoxorubicin in patients with solid Tumors.
- Lanreotide in metastatic enteropancreatic Neuroendocrine tumors.
- Primary hepatoCellular carcinoma ("hepatoid" carcinoma) of the pancreas: a case report and review of the literature.
- Safety, tolerability, pharmacokinetics, and pharmacodynamics of a long-acting release (LAR) formulation of pasireotide (SOM230) in patients with gastroenteropancreatic...
- Small bowel carcinoid: Location isn't everything!
- Mixed acinar-endocrine Carcinoma of the pancreas: new clinical and pathological features in a contemporary series.
- Radioembolization for treatment of Liver metastases from neuroendocrine tumors: correlation with imaging and biomarkers.
- PI3K/Akt/mTOR Pathway Inhibitors in the Therapy of Pancreatic Neuroendocrine Tumors.
- Ki-67 proliferative index predicts progression-free survival of patients with well-differentiated ileal Neuroendocrine tumors.
- Concurrent primary hyperparathyroidism and humOral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1.
- Pancreatic Neuroendocrine tumors: presentation, management, and outcomes.
- Metabolic and receptor imaging in patients with Neuroendocrine tumors: comparison of fludeoxyglucose-positron emission tomography and computed tomography with indium i...
- Everolimus plus octreotide long-acting repeatable for the treatment of advanced Neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, pl...
- A multiinstitutional evaluation of the analgesic efficacy and safety of ketorolac tromethamine, acetaminophen plus codeine, and placebo in Cancer pain.
- Uptake of the yolk protein, lipovitellin, by developing crustacean oocytes.
- Everolimus for advanced pancreatic Neuroendocrine tumors.
- Spared Adrenals: transient florid ectopic Cushing syndrome associated with necrosis of metastatic carcinoid.
- Morphologic features of carcinoid heart Disease as assessed by three-dimensional transesophageal echocardiography.
- Docetaxel and carboplatin as first-line therapy in advanced non-small Cell lung carcinoma: a phase II study.
Schools
Yale University School Of Medicine
Stanford University Hospital
Standford University Hospital
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Basal Cell Carcinoma
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Patient’s Choice Physician Award
- Excellence Award
- Member
- Class of 1911 Prize – Most Outstanding Undergraduate Thesis
- Super Doctor
Education
-
Stanford University -
Yale University School of Medicine
Hospital
-
Montefiore Medical Center -
Cedars-Sinai Medical Center
Drug Facts
| NPI NUMBER | 1780658070 | |
| NPPES Provider LastName | WOLIN | |
| NPPES Provider FirstName | EDWARD | |
| NPPES Provider ZIPCode | 405360093 | |
| NPPES Provider State | KY | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 213.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1780658070 |
| Last Name Of The Provider | WOLIN |
| First Name Of The Provider | EDWARD |
| View All |
Similar Doctors
|
|
Dr. Robert A. Figlin, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ronald B. Natale, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Charles A. Forscher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James R. Berenson, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Daphne B. Stewart, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory P. Sarna, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amir S. Steinberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Audeh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael B. Engelberg, MD
This Doctor is OpenDoctor Recommended.
|